Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F

Journal of Biological Chemistry(2021)10.1016/j.jbc.2021.101365Source: DataRank Database

Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F is a research paper published in Journal of Biological Chemistry (2021). On theSindex it has a DataRank of 0. It has been cited 65 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access65 citations

Download PDF

Cite:

Linked data & code

geo

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (3 grants)Impact (FWCI 6.14)OA: goldTopics (30)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (4)

Samkeliso Dlamini ORCID,L. M. Viranga Tillekeratne ORCID,William R. Taylor ORCID,Nishanth Kuganesan

Live enrichment

PubMed:34728216 PMC:PMC8661017 OpenAlex:https://openalex.org/W3209230329

National Institutes of Health

Grant: R15CA213185

National Institutes of Health

Grant: R15GM120712

National Institutes of Health

Grant: R15GM141712

FWCI

6.14

Citation Percentile

1.0%

Citation Trend

2022

2023

2024

2025

2026

goldLicense: cc-by

journalhttp://www.jbc.org/article/S0021925821011716/pdf

publisherhttp://www.jbc.org/article/S0021925821011716/pdf

publisherhttps://api.elsevier.com/content/article/PII:S0021925821011716?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0021925821011716?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jbc.2021.101365

Fields of Study

Ferroptosis and cancer prognosisRNA modifications and cancerCancer, Lipids, and Metabolism

MeSH Terms

FerroptosisAnimalsCells, CulturedHumansTumor Suppressor Protein p53Retinoblastoma ProteinMice, KnockoutCyclin-Dependent KinasesCell Line, TumorE2F1 Transcription FactorCyclin-Dependent Kinase Inhibitor p21Mice

Keywords

Oxidative stressSuppressorCyclin-dependent kinaseCancer researchE2FCell biologyChemistryBiologyApoptosisBiochemistryCell cycleGeneCyclin ERetinoblastoma proteinFerroptosis

Sustainable Development Goals

SDG 0: Good health and well-being

Tumor suppressor p53 promotes ferroptosis in oxidative stress conditions independent of modulation of ferroptosis by p21, CDKs, RB, and E2F

FAIR Checklist

Authors (4)

Funding (3 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)